Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema

Publisher： Karger

E-ISSN： 1663-2699|6|1|44-50

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.6, Iss.1, 2015-02, pp. : 44-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early Response to Ranibizumab Is Associated with 12-Month Outcome in Diabetic Macular Edema after Prior Macular Laser Therapy

By  

Ophthalmologica, Vol. 238, Iss. 3, 2017-07 ,pp. : 139-146

Karger

Access to resources Recommend Favorite

Comparison of the Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema in Vitrectomized and Nonvitrectomized Eyes

By  

Ophthalmologica, Vol. 236, Iss. 2, 2016-07 ,pp. : 67-73

Karger

Access to resources Recommend Favorite

Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema

By  

Ophthalmologica, Vol. 232, Iss. 3, 2014-08 ,pp. : 136-143

Karger

Access to resources Recommend Favorite

Dexamethasone Implant in Chronic Diabetic Macular Edema Resistant to Intravitreal Ranibizumab Treatment

By  

Ophthalmic Research, Vol. 57, Iss. 3, 2016-12 ,pp. : 161-165

Karger

Access to resources Recommend Favorite

Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab

By Kanoff Justin   Miller Joan  

Seminars in Ophthalmology, Vol. 28, Iss. 5-6, 2013-09 ,pp. : 355-360

Informa Healthcare

Access to resources Recommend Favorite